Order Article Reprints

Vassallo V, Di Meo C, Toro G, Alfano A, Iolascon G, Schiraldi C. Correction: Vassallo et al. Hyaluronic Acid-Based Injective Medical Devices: In Vitro Characterization of Novel Formulations Containing Biofermentative Unsulfated Chondroitin or Extractive Sulfated One with Cyclodextrins. Pharmaceuticals 2023, 16, 1429. Pharmaceuticals. 2023; 16(12):1685. https://doi.org/10.3390/ph16121685

Vassallo, Valentina, Celeste Di Meo, Giuseppe Toro, Alberto Alfano, Giovanni Iolascon, and Chiara Schiraldi. 2023. "Correction: Vassallo et al. Hyaluronic Acid-Based Injective Medical Devices: In Vitro Characterization of Novel Formulations Containing Biofermentative Unsulfated Chondroitin or Extractive Sulfated One with Cyclodextrins. Pharmaceuticals 2023, 16, 1429" Pharmaceuticals 16, no. 12: 1685. https://doi.org/10.3390/ph16121685

Vassallo, V., Di Meo, C., Toro, G., Alfano, A., Iolascon, G., & Schiraldi, C. (2023). Correction: Vassallo et al. Hyaluronic Acid-Based Injective Medical Devices: In Vitro Characterization of Novel Formulations Containing Biofermentative Unsulfated Chondroitin or Extractive Sulfated One with Cyclodextrins. Pharmaceuticals 2023, 16, 1429. Pharmaceuticals, 16(12), 1685. https://doi.org/10.3390/ph16121685